MétaCan
Menu
Back to cohort
Record W4318293174 · doi:10.1016/j.euo.2023.01.003

Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting

2023· article· en· W4318293174 on OpenAlexaff
Caroline M. Moore, Lauren E. King, John Withington, Mahul B. Amin, Mark Andrews, Erik Briers, Ronald C. Chen, Francis Chinegwundoh, Matthew R. Cooperberg, Jane Crowe, Antonio Finelli, Margaret I. Fitch, Mark Frydenberg, Francesco Giganti, Masoom A. Haider, John Freeman, Joseph J. Gallo, S. Julian Gibbs, Anthony Henry, Nicholas D. James, Netty Kinsella, Thomas Lam, Mark Lichty, Stacy Loeb, Brandon A. Mahal, Ken Mastris, Anita Mitra, Samuel WD Merriel, Theodorus van der Kwast, Mieke Van Hemelrijck, Nynikka R. Palmer, Catherine Paterson, Monique J. Roobol, Phillip Segal, James A. Schraidt, Camille E. Short, M. Minhaj Siddiqui, Clare M. Tempany, Arnaud Villers, Howard Wolinsky, Steven MacLennan

Bibliographic record

VenueEuropean Urology Oncology · 2023
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Diagnosis and Treatment
Canadian institutionsProstate Cancer CanadaOccupational Cancer Research CentreLunenfeld-Tanenbaum Research InstituteSinai Health SystemPrincess Margaret Cancer CentreUniversity of TorontoUniversity Health Network
FundersNational Institute for Health and Care ResearchMovember Foundation
KeywordsMedicineProstate cancerRectal examinationLikert scaleBest practiceMedical physicsFamily medicineProstate-specific antigenCancerInternal medicinePsychology

Abstract

fetched live from OpenAlex

BACKGROUND: Active surveillance (AS) is recommended for low-risk and some intermediate-risk prostate cancer. Uptake and practice of AS vary significantly across different settings, as does the experience of surveillance-from which tests are offered, and to the levels of psychological support. OBJECTIVE: To explore the current best practice and determine the most important research priorities in AS for prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: A formal consensus process was followed, with an international expert panel of purposively sampled participants across a range of health care professionals and researchers, and those with lived experience of prostate cancer. Statements regarding the practice of AS and potential research priorities spanning the patient journey from surveillance to initiating treatment were developed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Panel members scored each statement on a Likert scale. The group median score and measure of consensus were presented to participants prior to discussion and rescoring at panel meetings. Current best practice and future research priorities were identified, agreed upon, and finally ranked by panel members. RESULTS AND LIMITATIONS: There was consensus agreement that best practice includes the use of high-quality magnetic resonance imaging (MRI), which allows digital rectal examination (DRE) to be omitted, that repeat standard biopsy can be omitted when MRI and prostate-specific antigen (PSA) kinetics are stable, and that changes in PSA or DRE should prompt MRI ± biopsy rather than immediate active treatment. The highest ranked research priority was a dynamic, risk-adjusted AS approach, reducing testing for those at the least risk of progression. Improving the tests used in surveillance, ensuring equity of access and experience across different patients and settings, and improving information and communication between and within clinicians and patients were also high priorities. Limitations include the use of a limited number of panel members for practical reasons. CONCLUSIONS: The current best practice in AS includes the use of high-quality MRI to avoid DRE and as the first assessment for changes in PSA, with omission of repeat standard biopsy when PSA and MRI are stable. Development of a robust, dynamic, risk-adapted approach to surveillance is the highest research priority in AS for prostate cancer. PATIENT SUMMARY: A diverse group of experts in active surveillance, including a broad range of health care professionals and researchers and those with lived experience of prostate cancer, agreed that best practice includes the use of high-quality magnetic resonance imaging, which can allow digital rectal examination and some biopsies to be omitted. The highest research priority in active surveillance research was identified as the development of a dynamic, risk-adjusted approach.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.416
metaresearch head score (Gemma)0.253
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.416
Threshold uncertainty score0.720

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.4160.253
Meta-epidemiology (narrow)0.0030.003
Meta-epidemiology (broad)0.0050.010
Bibliometrics0.0100.009
Science and technology studies0.0070.005
Scholarly communication0.0140.014
Open science0.0160.025
Research integrity0.0220.024
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.082
GPT teacher head0.445
Teacher spread0.363 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations47
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Urology OncologySame topicProstate Cancer Diagnosis and TreatmentFrench-language works237,207